Literature DB >> 20860919

Animal models of IBD: linkage to human disease.

Atsushi Mizoguchi1, Emiko Mizoguchi.   

Abstract

Spontaneous development of intestinal inflammation in many different kinds of genetically engineered mice as well as the presence of numerous susceptibility genes in humans suggests that inflammatory bowel disease (IBD) is mediated by more complicated mechanisms than previously predicted. The human genetic studies implicate some major pathways in the pathogenesis of IBD, including epithelial defense against commensal microbiota, the IL-23/Th17 axis, and immune regulation. Murine IBD models, which are genetically engineered to lack some susceptibility genes, have been generated, and have provided useful insights into the therapeutic potential of targeting the susceptibility genes directly or their downstream pathways indirectly for IBD. This review summarizes current information related to the function of IBD-associated genes as derived from genetically engineered mouse models.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20860919      PMCID: PMC3176311          DOI: 10.1016/j.coph.2010.05.007

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  119 in total

1.  Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract.

Authors:  Koichi S Kobayashi; Mathias Chamaillard; Yasunori Ogura; Octavian Henegariu; Naohiro Inohara; Gabriel Nuñez; Richard A Flavell
Journal:  Science       Date:  2005-02-04       Impact factor: 47.728

2.  T helper 1-inducing property of IL-27/WSX-1 signaling is required for the induction of experimental colitis.

Authors:  Kuniomi Honda; Kazuhiko Nakamura; Noriaki Matsui; Makoto Takahashi; Yousuke Kitamura; Takahiro Mizutani; Naohiko Harada; Hajime Nawata; Shinjiro Hamano; Hiroki Yoshida
Journal:  Inflamm Bowel Dis       Date:  2005-12       Impact factor: 5.325

3.  STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity.

Authors:  Thomas Welte; Samuel S M Zhang; Tian Wang; Zhiyuan Zhang; David G T Hesslein; Zhinan Yin; Arihiro Kano; Yoshiki Iwamoto; En Li; Joseph E Craft; Alfred L M Bothwell; Erol Fikrig; Pandelakis A Koni; Richard A Flavell; Xin-Yuan Fu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-05       Impact factor: 11.205

4.  Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid.

Authors:  Daniel Mucida; Yunji Park; Gisen Kim; Olga Turovskaya; Iain Scott; Mitchell Kronenberg; Hilde Cheroutre
Journal:  Science       Date:  2007-06-14       Impact factor: 47.728

5.  Epithelial NEMO links innate immunity to chronic intestinal inflammation.

Authors:  Arianna Nenci; Christoph Becker; Andy Wullaert; Ralph Gareus; Geert van Loo; Silvio Danese; Marion Huth; Alexei Nikolaev; Clemens Neufert; Blair Madison; Deborah Gumucio; Markus F Neurath; Manolis Pasparakis
Journal:  Nature       Date:  2007-03-14       Impact factor: 49.962

6.  CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.

Authors:  Paul A Blair; Lina Yassin Noreña; Fabian Flores-Borja; David J Rawlings; David A Isenberg; Michael R Ehrenstein; Claudia Mauri
Journal:  Immunity       Date:  2010-01-14       Impact factor: 31.745

7.  Inducible IL-12-producing B cells regulate Th2-mediated intestinal inflammation.

Authors:  Ken Sugimoto; Atsuhiro Ogawa; Yasuyo Shimomura; Kiyotaka Nagahama; Atsushi Mizoguchi; Atul K Bhan
Journal:  Gastroenterology       Date:  2007-04-14       Impact factor: 22.682

8.  MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokine-dependent immunity.

Authors:  Jacqueline G Perrigoue; Steven A Saenz; Mark C Siracusa; Eric J Allenspach; Betsy C Taylor; Paul R Giacomin; Meera G Nair; Yurong Du; Colby Zaph; Nico van Rooijen; Michael R Comeau; Edward J Pearce; Terri M Laufer; David Artis
Journal:  Nat Immunol       Date:  2009-05-24       Impact factor: 25.606

9.  Common variants at five new loci associated with early-onset inflammatory bowel disease.

Authors:  Marcin Imielinski; Robert N Baldassano; Anne Griffiths; Richard K Russell; Vito Annese; Marla Dubinsky; Subra Kugathasan; Jonathan P Bradfield; Thomas D Walters; Patrick Sleiman; Cecilia E Kim; Aleixo Muise; Kai Wang; Joseph T Glessner; Shehzad Saeed; Haitao Zhang; Edward C Frackelton; Cuiping Hou; James H Flory; George Otieno; Rosetta M Chiavacci; Robert Grundmeier; Massimo Castro; Anna Latiano; Bruno Dallapiccola; Joanne Stempak; Debra J Abrams; Kent Taylor; Dermot McGovern; Gary Silber; Iwona Wrobel; Antonio Quiros; Jeffrey C Barrett; Sarah Hansoul; Dan L Nicolae; Judy H Cho; Richard H Duerr; John D Rioux; Steven R Brant; Mark S Silverberg; Kent D Taylor; M Michael Barmuda; Alain Bitton; Themistocles Dassopoulos; Lisa Wu Datta; Todd Green; Anne M Griffiths; Emily O Kistner; Michael T Murtha; Miguel D Regueiro; Jerome I Rotter; L Philip Schumm; A Hillary Steinhart; Stephen R Targan; Ramnik J Xavier; Cécile Libioulle; Cynthia Sandor; Mark Lathrop; Jacques Belaiche; Olivier Dewit; Ivo Gut; Simon Heath; Debby Laukens; Myriam Mni; Paul Rutgeerts; André Van Gossum; Diana Zelenika; Denis Franchimont; J P Hugot; Martine de Vos; Severine Vermeire; Edouard Louis; Lon R Cardon; Carl A Anderson; Hazel Drummond; Elaine Nimmo; Tariq Ahmad; Natalie J Prescott; Clive M Onnie; Sheila A Fisher; Jonathan Marchini; Jilur Ghori; Suzannah Bumpstead; Rhian Gwillam; Mark Tremelling; Panos Delukas; John Mansfield; Derek Jewell; Jack Satsangi; Christopher G Mathew; Miles Parkes; Michel Georges; Mark J Daly; Melvin B Heyman; George D Ferry; Barbara Kirschner; Jessica Lee; Jonah Essers; Richard Grand; Michael Stephens; Arie Levine; David Piccoli; John Van Limbergen; Salvatore Cucchiara; Dimitri S Monos; Stephen L Guthery; Lee Denson; David C Wilson; Straun F A Grant; Mark Daly; Mark S Silverberg; Jack Satsangi; Hakon Hakonarson
Journal:  Nat Genet       Date:  2009-11-15       Impact factor: 38.330

10.  Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation.

Authors:  Craig A Murphy; Claire L Langrish; Yi Chen; Wendy Blumenschein; Terrill McClanahan; Robert A Kastelein; Jonathon D Sedgwick; Daniel J Cua
Journal:  J Exp Med       Date:  2003-12-08       Impact factor: 14.307

View more
  37 in total

Review 1.  The Costs of Living Together: Immune Responses to the Microbiota and Chronic Gut Inflammation.

Authors:  Lucas J Kirschman; Kathryn C Milligan-Myhre
Journal:  Appl Environ Microbiol       Date:  2019-05-02       Impact factor: 4.792

2.  NHE3 modulates the severity of colitis in IL-10-deficient mice.

Authors:  C B Larmonier; D Laubitz; R D Thurston; A L Bucknam; F M Hill; M Midura-Kiela; R Ramalingam; P R Kiela; F K Ghishan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-03-17       Impact factor: 4.052

3.  The membrane-bound mucin Muc1 regulates T helper 17-cell responses and colitis in mice.

Authors:  Atsushi Nishida; Cindy W Lau; Mei Zhang; Akira Andoh; Hai Ning Shi; Emiko Mizoguchi; Atsushi Mizoguchi
Journal:  Gastroenterology       Date:  2011-12-24       Impact factor: 22.682

4.  SHIP-deficient mice develop spontaneous intestinal inflammation and arginase-dependent fibrosis.

Authors:  Keith W McLarren; Alexandra E Cole; Shelley B Weisser; Nicole S Voglmaier; Victoria S Conlin; Kevan Jacobson; Oana Popescu; Jean-Luc Boucher; Laura M Sly
Journal:  Am J Pathol       Date:  2011-05-07       Impact factor: 4.307

5.  Patchouli oil ameliorates acute colitis: A targeted metabolite analysis of 2,4,6-trinitrobenzenesulfonic acid-induced rats.

Authors:  Xiuting Yu; Guanghua Yang; Hua Jiang; Shuhai Lin; Yuhong Liu; Xie Zhang; Huifang Zeng; Ziren Su; Song Huang; Linlin Shen; Xiaojun Zhang
Journal:  Exp Ther Med       Date:  2017-06-12       Impact factor: 2.447

6.  Reversing Ongoing Chronic Intestinal Inflammation and Fibrosis by Sustained Block of IL-12 and IL-23 Using a Vaccine in Mice.

Authors:  Qingdong Guan; Carolyn R Weiss; Shuhe Wang; Gefei Qing; Xi Yang; Richard J Warrington; Charles N Bernstein; Zhikang Peng
Journal:  Inflamm Bowel Dis       Date:  2018-08-16       Impact factor: 5.325

Review 7.  Alternative medicines as emerging therapies for inflammatory bowel diseases.

Authors:  Udai P Singh; Narendra P Singh; Brandon Busbee; H Guan; Balwan Singh; Robert L Price; Dennis D Taub; Manoj K Mishra; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Int Rev Immunol       Date:  2012-02       Impact factor: 5.311

Review 8.  Genetically engineered mouse models for studying inflammatory bowel disease.

Authors:  Atsushi Mizoguchi; Takahito Takeuchi; Hidetomo Himuro; Toshiyuki Okada; Emiko Mizoguchi
Journal:  J Pathol       Date:  2015-11-14       Impact factor: 7.996

Review 9.  Potential association between TLR4 and chitinase 3-like 1 (CHI3L1/YKL-40) signaling on colonic epithelial cells in inflammatory bowel disease and colitis-associated cancer.

Authors:  A Kamba; I-A Lee; E Mizoguchi
Journal:  Curr Mol Med       Date:  2013-08       Impact factor: 2.222

10.  Beneficial Effects of Fecal Microbiota Transplantation on Ulcerative Colitis in Mice.

Authors:  Zhihui Tian; Jie Liu; Mengyu Liao; Wenjuan Li; Jiaqi Zou; Xinxin Han; Mingjie Kuang; Wanqiu Shen; Haidong Li
Journal:  Dig Dis Sci       Date:  2016-02-05       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.